13F-HR/A filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2018-12-31, filed 2023-11-08, with 54 holding rows worth $184,674,320.
- Accession
- 0001697013-23-000010
- Filer
- CIK 1697013
- Filed
- 2023-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, amendment of type restatement, 54 entries on the cover page, a total value of $184,674,320 stated on the cover page (in dollars after the unit check, H1), rows summing to $184,674,320 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZOGENIX INC. | 98978L204 | Common Stock | 563,429 | $20,542,621 | dollars as filed | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 529,484 | $20,391,894 | dollars as filed | |
| R1 RCM INC | 749397105 | COM | 2,349,306 | $18,676,983 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,263,407 | $17,194,969 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 306,242 | $13,293,965 | dollars as filed | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 552,053 | $9,103,354 | dollars as filed | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 232,790 | $8,403,719 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 36,492 | $6,047,089 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 47,804 | $4,936,613 | dollars as filed | |
| ABIOMED INC | 003654100 | COM | 13,939 | $4,530,733 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 40,494 | $4,419,110 | dollars as filed | |
| MYLAN NV | N59465109 | SHS EURO | 158,600 | $4,345,640 | dollars as filed | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 38,224 | $3,672,180 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 45,800 | $3,527,912 | dollars as filed | |
| ENSIGN GROUP INC | 29358P101 | COM | 85,575 | $3,323,165 | dollars as filed | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 81,371 | $3,169,400 | dollars as filed | |
| TELIGENT INC NEW | 87960W104 | COM | 2,247,476 | $3,079,042 | dollars as filed | |
| TESARO INC | 881569107 | COM | 36,000 | $2,673,000 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 31,400 | $2,271,162 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 165,000 | $2,116,950 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 55,300 | $1,905,085 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 5,148 | $1,544,040 | dollars as filed | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 23,866 | $1,537,209 | dollars as filed | |
| MYLAN NV | N59465109 | SHS EURO | 55,000 | $1,507,000 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 69,700 | $1,463,003 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 106,880 | $1,409,747 | dollars as filed | |
| LOXO ONCOLOGY INC | 548862101 | COM | 10,000 | $1,400,700 | dollars as filed | |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 22,000 | $1,333,200 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 163,959 | $1,323,149 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 205,104 | $1,294,206 | dollars as filed | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 90,412 | $1,288,371 | dollars as filed | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 294,660 | $1,057,829 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 335,774 | $1,044,257 | dollars as filed | |
| CARETRUST REIT INC COM | 14174T107 | REIT | 51,264 | $956,199 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 15,254 | $955,663 | dollars as filed | |
| TRICIDA INC | 89610F101 | COM | 40,522 | $955,509 | dollars as filed | |
| ARQULE INC | 04269E107 | COM | 344,618 | $954,592 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 42,301 | $860,825 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 8,271 | $792,279 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 2,300 | $604,049 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 62,750 | $601,145 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 39,539 | $551,964 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 4,300 | $495,790 | dollars as filed | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 18,029 | $442,251 | dollars as filed | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 41,074 | $439,081 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 50,455 | $434,922 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 47,096 | $370,646 | dollars as filed | |
| INVACARE CORP | 461203101 | COMMON STOCK | 73,902 | $317,779 | dollars as filed | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 15,459 | $281,972 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 65,000 | $266,500 | dollars as filed | |
| OPIANT PHARMACEUTICALS INC | 683750103 | COM | 13,901 | $200,869 | dollars as filed | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 73,717 | $159,229 | dollars as filed | |
| EPIZYME INC | 29428V104 | COM | 25,449 | $156,766 | dollars as filed | |
| CONFORMIS INC | 20717E101 | COM | 136,851 | $48,993 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001697013-19-000003 | superseded | 2019-02-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000010 | this filing | 2023-11-08 | acceptance time not in the bulk data set |